The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids

European Journal of Immunology

Volumn 40, Issue 1, 2010, Pages 186-196

  Liu, Bin ^a   Wilson, Eric ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Antimicrobial peptide; CCL28; Chemokines; Innate immunity

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; CHEMOKINE CCL28; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; AMINO ACID; CCL28 PROTEIN, MOUSE;

AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE DELETION; GENE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; MICROBIAL VIABILITY; MOLECULAR GENETICS; MOUSE; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; CHEMOKINES, CC; CONSERVED SEQUENCE; HUMANS; MICE; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT;

EID: 74249102743     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939819     Document Type: Article

References (49)

1. Allen, S. J., Crown, S. E. and Handel, T. M., Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 2007. 25: 787-820.
2. Butcher, E. C. and Picker, L. J., Lymphocyte homing and homeostasis. Science 1996. 272: 60-66.
3. Esche, C., Stellato, C. and Beck, L. A., Chemokines: key players in innate and adaptive immunity. J. Invest. Dermatol. 2005. 125: 615-628.
4. Lukacs, N. W., Role of chemokines in the pathogenesis of asthma. Nat. Rev. Immunol. 2001. 1: 108-116.
5. Linge, H. M., Collin, M., Nordenfelt, P., Morgelin, M., Malmsten, M. and Egesten, A., The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial. Antimicrob. Agents Chemother. 2008. 52: 2599-2607.
6. Nakayama, T., Shirane, J., Hieshima, K., Shibano, M., Watanabe, M., Jin, Z., Nagakubo, D. et al., Novel antiviral activity of chemokines. Virology 2006. 350: 484-492.
7. Yang, D., Chen, Q., Hoover, D. M., Staley, P., Tucker, K. D., Lubkowski, J. and Oppenheim, J. J., Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J. Leukoc. Biol. 2003. 74: 448-455.
8. Lazarus, N. H., Kunkel, E. J., Johnston, B., Wilson, E., Youngman, K. R. and Butcher, E. C., A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J. Immunol. 2003. 170: 3799-3805.
9. Wilson, E. and Butcher, E. C., CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J. Exp. Med. 2004. 200: 805-809.
10. Hieshima, K., Ohtani, H., Shibano, M., Izawa, D., Nakayama, T., Kawasaki, Y., Shiba, F. et al., CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J. Immunol. 2003. 170: 1452-1461.
11. Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y. and Bevins, C. L., Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003. 422: 522-526.
12. Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., Lopez-Boado, Y. S., Stratman, J. L., Hultgren, et al., Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999. 286: 113-117.
13. Giangaspero, A., Sandri, L. and Tossi, A., Amphipathic alpha helical antimicrobial peptides. Eur. J. Biochem. 2001. 268: 5589-5600.
14. Huang, H. W., Action of antimicrobial peptides: two-state model. Biochemistry 2000. 39: 8347-8352.
15. Shai, Y., Mode of action of membrane active antimicrobial peptides. Biopolymers 2002. 66: 236-248.
16. Hoover, D. M., Wu, Z., Tucker, K., Lu, W. and Lubkowski, J., Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob. Agents Chemother. 2003. 47: 2804-2809.
17. Pazgier, M., Prahl, A., Hoover, D. M. and Lubkowski, J., Studies of the biological properties of human beta-defensin 1. J. Biol. Chem. 2007. 282: 1819-1829.
18. Powers, J. P. and Hancock, R. E., The relationship between peptide structure and antibacterial activity. Peptides 2003. 24: 1681-1691.
19. Tanabe, H., Qu, X., Weeks, C. S., Cummings, J. E., Kolusheva, S., Walsh, K. B., Jelinek, R. et al., Structure-activity determinants in paneth cell alpha-defensins: loss-of-function in mouse cryptdin-4 by charge-reversal at arginine residue positions. J. Biol. Chem. 2004. 279: 11976-11983.
20. Taylor, K., Barran, P. E. and Dorin, J. R., Structure-activity relationships in beta-defensin peptides. Biopolymers 2008. 90: 1-7.
21. Taylor, K., Clarke, D. J., McCullough, B., Chin, W., Seo, E., Yang, D., Oppenheim, J. et al., Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3. J. Biol. Chem. 2008. 283: 6631-6639.
22. Wu, Z., Li, X., de Leeuw, E., Ericksen, B. and Lu, W., Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins? J. Biol. Chem. 2005. 280: 43039-43047.
23. Xie, C., Prahl, A., Ericksen, B., Wu, Z., Zeng, P., Li, X., Lu, W. Y. et al., Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. J. Biol. Chem. 2005. 280: 32921-32929.
24. Zou, G., de Leeuw, E., Li, C., Pazgier, M., Li, C., Zeng, P., Lu, W. Y. et al., Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs. J. Biol. Chem. 2007. 282: 19653-19665.
25. Shaw, J. P., Johnson, Z., Borlat, F., Zwahlen, C., Kungl, A., Roulin, K., Harrenga, A. et al., The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure 2004. 12: 2081-2093.
26. Homey, B., Wang, W., Soto, H., Buchanan, M. E., Wiesenborn, A., Catron, D., Muller, A. et al., Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skinassociated chemokine CCL27 (CTACK/ALP/ILC). J. Immunol. 2000. 164: 3465-3470.
27. Chan, D. I., Hunter, H. N., Tack, B. F. and Vogel, H. J., Human macrophage inflammatory protein 3alpha: protein and peptide nuclear magnetic resonance solution structures, dimerization, dynamics, and anti-infective properties. Antimicrob. Agents Chemother. 2008. 52: 883-894.
28. Hemmerich, S., Paavola, C., Bloom, A., Bhakta, S., Freedman, R., Grunberger, D., Krstenansky, J. et al., Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry 1999. 38: 13013-13025.
29. Hoover, D. M., Boulegue, C., Yang, D., Oppenheim, J. J., Tucker, K., Lu, W. and Lubkowski, J., The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J. Biol. Chem. 2002. 277: 37647-37654.
30. Ott, T. R., Lio, F. M., Olshefski, D., Liu, X. J., Struthers, R. S. and Ling, N., Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta). Biochemistry 2004. 43: 3670-3678.
31. Prado, G. N., Suetomi, K., Shumate, D., Maxwell, C., Ravindran, A., Rajarathnam, K. and Navarro, J., Chemokine signaling specificity: essential role for the N-terminal domain of chemokine receptors. Biochemistry 2007. 46: 8961-8968.
32. Rajagopalan, L. and Rajarathnam, K., Structural basis of chemokine receptor function - a model for binding affinity and ligand selectivity. Biosci. Rep. 2006. 26: 325-339.
33. Zasloff, M., Antimicrobial peptides of multicellular organisms. Nature 2002. 415: 389-395.
34. Eksteen, B., Miles, A., Curbishley, S. M., Tselepis, C., Grant, A. J., Walker, L. S. and Adams, D. H., Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J. Immunol. 2006. 177: 593-603.
35. Hansson, M., Hermansson, M., Svensson, H., Elfvin, A., Hansson, L. E., Johnsson, E., Sjoling, A. and Quiding-Jarbrink, M., CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells. Infect. Immun. 2008. 76: 3304-3311.
36. Chertov, O., Michiel, D. F., Xu, L., Wang, J. M., Tani, K., Murphy, W. J., Longo, D. L. et al., Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 1996. 271: 2935-2940.
37. Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M. et al., Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999. 286: 525-528.
38. Handel, T. M., Johnson, Z., Crown, S. E., Lau, E. K. and Proudfoot, A. E., Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu. Rev. Biochem. 2005. 74: 385-410.
39. Lau, E. K., Paavola, C. D., Johnson, Z., Gaudry, J. P., Geretti, E., Borlat, F., Kungl, A. J. et al., Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J. Biol. Chem. 2004. 279: 22294-22305.
40. Lortat-Jacob, H., Grosdidier, A. and Imberty, A., Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl. Acad. Sci. USA 2002. 99: 1229-1234.
41. Kluver, E., Schulz-Maronde, S., Scheid, S., Meyer, B., Forssmann, W. G. and Adermann, K., Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 2005. 44: 9804-9816.
42. Rajarathnam, K., Sykes, B. D., Dewald, B., Baggiolini, M. and Clark-Lewis, I., Disulfide bridges in interleukin-8 probed using non-natural disulfide analogues: dissociation of roles in structure from function. Biochemistry 1999. 38: 7653-7658.
43. Ramamoorthy, A., Thennarasu, S., Tan, A., Gottipati, K., Sreekumar, S., Heyl, D. L., An, F. Y. and Shelburne, C. E., Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding. Biochemistry 2006. 45: 6529-6540.
44. Wu, Z., Hoover, D. M., Yang, D., Boulegue, C., Santamaria, F., Oppenheim, J. J., Lubkowski, J. and Lu, W., Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. USA 2003. 100: 8880-8885.
45. Campagna, S., Saint, N., Molle, G. and Aumelas, A., Structure and mechanism of action of the antimicrobial peptide piscidin. Biochemistry 2007. 46: 1771-1778.
46. Lourenzoni, M. R., Namba, A. M., Caseli, L., Degreve, L. and Zaniquelli, M. E., Study of the interaction of human defensins with cell membrane models: relationships between structure and biological activity. J. Phys. Chem. B 2007. 111: 11318-11329.
47. Mani, R., Cady, S. D., Tang, M., Waring, A. J., Lehrer, R. I. and Hong, M., Membrane-dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR. Proc. Natl. Acad. Sci USA 2006. 103: 16242-16247.
48. Schibli, D. J., Hunter, H. N., Aseyev, V., Starner, T. D., Wiencek, J. M., McCray, P. B., Jr., Tack, B. F. and Vogel, H. J., The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. 2002. 277: 8279-8289.
49. Shen, B., Methods in Molecular Biology: PCR Cloning Protocols, 2nd Edn., Humana Press Inc, Totowa, NJ 2002.